Pharming Group (PHGUF)
0.9286
-0.03
(-2.65%)
USD |
OTCM |
May 31, 16:00
Pharming Group Enterprise Value: 558.27M for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 31, 2024 | 558.27M |
May 30, 2024 | 575.28M |
May 29, 2024 | 575.28M |
May 28, 2024 | 575.28M |
May 24, 2024 | 575.28M |
May 23, 2024 | 575.28M |
May 22, 2024 | 575.28M |
May 21, 2024 | 575.28M |
May 20, 2024 | 575.28M |
May 17, 2024 | 575.28M |
May 16, 2024 | 575.28M |
May 15, 2024 | 575.28M |
May 14, 2024 | 575.28M |
May 13, 2024 | 575.28M |
May 10, 2024 | 575.28M |
May 09, 2024 | 575.28M |
May 08, 2024 | 575.28M |
May 07, 2024 | 575.28M |
May 06, 2024 | 575.28M |
May 03, 2024 | 575.28M |
May 02, 2024 | 575.28M |
May 01, 2024 | 575.28M |
April 30, 2024 | 575.28M |
April 29, 2024 | 575.28M |
April 26, 2024 | 575.28M |
Date | Value |
---|---|
April 25, 2024 | 542.52M |
April 24, 2024 | 572.69M |
April 23, 2024 | 572.69M |
April 22, 2024 | 572.69M |
April 19, 2024 | 572.69M |
April 18, 2024 | 572.69M |
April 17, 2024 | 572.69M |
April 16, 2024 | 650.13M |
April 15, 2024 | 650.13M |
April 12, 2024 | 650.13M |
April 11, 2024 | 650.13M |
April 10, 2024 | 650.13M |
April 09, 2024 | 741.04M |
April 08, 2024 | 741.04M |
April 05, 2024 | 741.04M |
April 04, 2024 | 741.04M |
April 03, 2024 | 741.04M |
April 02, 2024 | 741.04M |
April 01, 2024 | 741.04M |
March 31, 2024 | 741.04M |
March 28, 2024 | 730.29M |
March 27, 2024 | 730.29M |
March 26, 2024 | 730.29M |
March 25, 2024 | 730.29M |
March 22, 2024 | 730.29M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
431.05M
Minimum
May 12 2022
1.135B
Maximum
Dec 21 2020
704.78M
Average
713.51M
Median
Dec 31 2023
Enterprise Value Benchmarks
uniQure NV | -214.21M |
ProQR Therapeutics NV | 53.04M |
Merus NV | 2.787B |
argenx SE | 18.88B |
Enterprise Value Related Metrics
Net Income (Quarterly) | -12.45M |
Revenue (Quarterly) | 55.59M |
Total Expenses (Quarterly) | 71.90M |
EPS Diluted (Quarterly) | -0.019 |
Gross Profit Margin (Quarterly) | 84.91% |
Profit Margin (Quarterly) | -22.39% |
Earnings Yield | -1.72% |
Normalized Earnings Yield | -1.723 |